We help formulate your market access strategy and launch planning using the latest data, analytics, and market expertise – helping you make swift and accurate decisions.
Book a Consultation with an Expert30 min. consultation with a trusted advisor
GPI enables an agile approach no matter where you are on your journey
Opportunity & landscape assessment |
Develop evidence |
Value and price strategy |
Communicate |
Monitor and adapt |
Assess competitive landscape and plan market entry | Optimise product positioning | Perform price benchmarking | Build strong narratives | Use data to inform & reach incremental markets |
Access detailed insight on competitive drugs.Compare launch timelines and gain insights from historical data. Use time-to-reimbursement decisions and identify the optimal timing for your launch. |
Gain optimal reimbursement and price potential aligned to payer value.Adjust your evidence generation strategy to support a price premium. |
Analyse competitor product pricing.Estimate the optimal price point for your product across multiple markets. Navigate regulatory environments with access to pricing policies and legislative pricing changes. |
Prepare clear and impactful visuals, graphs and tables.Tailor new product launch information to meet the needs of each stakeholder. Be ready with evidence that contributes to a positive price negotiation and reimbursement decision. |
Uncover market opportunities for expansion with our IRP Matrix.Monitor competitors and minimise risk by staying informed. Identify additional indications for product expansion. |
Utilise in-depth evidence and analysis for your strategy. Our verified data and visualisations are available on one easy-to-use platform. Speed your time to market with informative graphs and charts that translate vast data sets into compelling narratives.
Our proprietary analytic models can show how to achieve price premiums. Adjust your TPP and build best-case and worst-case scenarios. Formulate your launch plan or revise your existing strategy using analytics and insight. Learn more about Value Assessment & Price Forecasting
Our platform lets you see IRP rules, time to market, and access potential, in one place so you can build the optimal global launch sequence.
Our market access experts develop strategies and actionable recommendations, from product due diligence, through to revenue optimisation. We can help you to accelerate your time to market or tune already launched products. Just ask.
Our qualified market experts can advise you on your
commercialisation plans.
We helped to optimise the launch sequence of three different phase II/III drugs across a range of (orphan) indications. This client was able to successfully build a pricing strategy across key markets to support optimal ROI.
Achieving your clinical and business objectives requires continuous adjustment: market monitoring, aligned expectations, and scenario-based thinking. Rethink your market access strategy.